KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Notes Payables (2016)

Bristol Myers Squibb (BMY) has disclosed Notes Payables for 8 consecutive years, with $155.0 million as the latest value for Q2 2016.

  • On a quarterly basis, Notes Payables fell 79.47% to $155.0 million in Q2 2016 year-over-year; TTM through Jun 2016 was $155.0 million, a 79.47% decrease, with the full-year FY2015 number at $139.0 million, down 76.44% from a year prior.
  • Notes Payables was $155.0 million for Q2 2016 at Bristol Myers Squibb, up from $106.0 million in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $1.4 billion in Q1 2013 to a low of $106.0 million in Q1 2016.
  • A 5-year average of $506.8 million and a median of $401.0 million in 2014 define the central range for Notes Payables.
  • Peak YoY movement for Notes Payables: surged 846.21% in 2013, then crashed 79.47% in 2016.
  • Bristol Myers Squibb's Notes Payables stood at $826.0 million in 2012, then plummeted by 56.54% to $359.0 million in 2013, then soared by 64.35% to $590.0 million in 2014, then tumbled by 76.44% to $139.0 million in 2015, then grew by 11.51% to $155.0 million in 2016.
  • Per Business Quant, the three most recent readings for BMY's Notes Payables are $155.0 million (Q2 2016), $106.0 million (Q1 2016), and $139.0 million (Q4 2015).